πŸ‡ΊπŸ‡Έ FDA
Patent

US 9517229

Treatment of breast cancer

granted A61KA61K31/4166A61K31/4184

Quick answer

US patent 9517229 (Treatment of breast cancer) held by The Regents of the University of Colorado, a Body Corporate expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/4166, A61K31/4184, A61P, A61P35/00